Big Pharma, UK Universities Launch 'Unique' Early Drug Development Fund
AstraZeneca plc, GlaxoSmithKline plc and Johnson & Johnson are investing £30m between them into a new fund aimed at advancing academic therapeutic research from three leading universities.